PCSK9 and familial hypercholesterolemia: For example, adenovirus-induced PCSK9 overexpression in a mouse model leads to lower hepatic LDLR expression and hypercholesterolemia, while ablation of the PCSK9 gene results in increased hepatic LDLR expression and lower circulating LDL-c levels.